Skip to content
Catalyst

PapersPMID:27038225

Acute p-synephrine ingestion increases fat oxidation rate during exercise.

British journal of clinical pharmacology2016The record ↗

findings
2
compound
1
endpoints
2
no difference found
1
  1. Finding, very limited evidenceraisesMaximal fat oxidation rate (MFO)
  2. Finding, very limited evidenceno difference foundWhole-body fat oxidation rate
Study, every finding
crossover
Dose studied, every finding
3 mg/kg p-synephrine, single oral dose
  • “Moreover, p-synephrine increased maximal fat oxidation rate (0.29 ± 0.15 vs. 0.40 ± 0.18 g min(-1) ; P = 0.01) during exercise although it did not affect the intensity at which maximal fat oxidation was achieved (55.8 ± 7.7 vs. 56.7 ± 8.2% VO2peak ; P = 0.51).”
    Population
    18 healthy subjects, during a cycle ergometer ramp test to volitional fatigue (25 W every 3 min), one acute dose against a cellulose placebo in a double-blind, randomised, counterbalanced two-trial design

What did not

  • “In comparison with the placebo, the ingestion of p-synephrine did not change energy consumption (1.6 ± 0.3 vs. 1.6 ± 0.3 kcal min(-1) ; P = 0.69) or fat oxidation rate at rest (0.08 ± 0.02 vs. 0.10 ± 0.04 g min(-1) ; P = 0.15).”
    Population
    18 healthy subjects, at rest, one acute dose against a cellulose placebo in a double-blind, randomised, counterbalanced two-trial design

Study record

Design
crossover trial
Species
human
Population
healthy subjects
Participants
18
Comparator
placebo
Duration
not reported
Endpoints measured
8
Declined
this platform holds no node for the endpoint